Hamartoma classification: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Hamartoma}}
{{Hamartoma}}
{{CMG}}
{{CMG}}{AE}}{{MV}}


==Overview==
==Overview==
Hamartomas may be classified into subtypes based on their '''location''' and '''associated conditions'''.


==Classification==
==Classification==
The literature describes several examples of hamartomas, including the following:
 
*[[Angiomyolipoma|Hemangioma]] and other vascular tumors that are not true neoplasms
Based on the genetic mutations, hereditary hamartomatous syndromes carry different gene mutations.
*[[Peutz-Jeghers syndrome]] of the bowel,
 
*Polyp of the large bowel
===Familial inheritance===
*Bronchial hamartoma
 
*[[Myocytic hamartoma|Hamartoma of heart]]
All the syndromes are inherited in the autosomal dominant manner and are conditioned by mutations in four genes, which are: BMPR1A, SMAD4, PTEN and STK11.
*[[Melanocytic nevus|Melanocytic nevi]]
 
*[[Neurofibromatosis|Neurofibromatosis in von Recklinghausen disease]]
* [[Juvenile polyposis syndrome]]  
*Neuroepithelial cells in tuberose sclerosis
* [[Peutz-Jeghers syndrome]]  
*[[Hypothalamic hamartoma|Hamartomas of the hypothalamus]] and [[tuber cinereum]]
* Hereditary mixed polyposis syndrome
*Hamartoma found in several location([[Multiple hamartoma syndrome]])
* PTEN hamartoma tumour syndrome
*A variety of bony hamartomas
* [[Cowden syndrome]]  
* Bannayan-Riley-Ruvalcaba syndrome
* Proteus’es syndrome
 
===Location===
Based on the location, hamartomas can be classified into the following sub-types:
 
'''* Bone-forming tumors'''
 
'''* Cartilage-forming tumors'''
 
'''* '''Fiber-forming tumors'''
::Nonossifying fibroma
::Fibrous dysplasia
::Mazabraud syndrome
 
'''* Benign non–matrix-forming tumors'''


==References==
==References==

Revision as of 17:31, 8 December 2015

Hamartoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hamartoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hamartoma classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hamartoma classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hamartoma classification

CDC on Hamartoma classification

Hamartoma classification in the news

Blogs on Hamartoma classification

Directions to Hospitals Treating Hamartoma

Risk calculators and risk factors for Hamartoma classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]{AE}}Maria Fernanda Villarreal, M.D. [2]

Overview

Hamartomas may be classified into subtypes based on their location and associated conditions.

Classification

Based on the genetic mutations, hereditary hamartomatous syndromes carry different gene mutations.

Familial inheritance

All the syndromes are inherited in the autosomal dominant manner and are conditioned by mutations in four genes, which are: BMPR1A, SMAD4, PTEN and STK11.

Location

Based on the location, hamartomas can be classified into the following sub-types:

* Bone-forming tumors

* Cartilage-forming tumors

* Fiber-forming tumors

Nonossifying fibroma
Fibrous dysplasia
Mazabraud syndrome

* Benign non–matrix-forming tumors

References


Template:WikiDoc Sources